Kellton Tech Solutions Approves Rights Issue to Raise Funds

New Delhi [India], September 23: Kellton Tech Solutions Ltd. has approved a proposal to raise funds through a rights issue of equity shares, according to a stock exchange filing dated September 23, 2026.

The company’s Board of Directors approved the fundraising plan at its meeting held on Wednesday. The proposed issue will comprise equity shares with a face value of ₹1 each and will be offered to eligible shareholders as of a record date, which will be determined and announced later.

However, the company has not yet disclosed key details of the proposed rights issue, including the issue size, issue price, rights entitlement ratio, record date, issue period and payment terms. These parameters will be finalised in accordance with applicable regulations and subsequently communicated to the stock exchanges.

The proposed fundraising remains subject to statutory, regulatory and other required approvals and will be undertaken in accordance with the Securities and Exchange Board of India (SEBI) ICDR Regulations and applicable provisions of the SEBI Listing Regulations.

The Board meeting commenced at 11:00 a.m. and concluded at 11:55 a.m. on September 23, 2026.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More